“Clinical efficacy of resveratrol as an adjuvant with meloxican in the treatment of knee osteoarthritis patients: A double-blind, randomised, placebo-controlled trial” (2018) Brazilian Journal of Pharmaceutical Sciences, 54(4), p. e17773. doi:10.1590/s2175-97902018000417773.